14006-54-3Relevant articles and documents
Polythienobenzothiophenes, a new family of electroactive polymers: Electrosynthesis, spectral characterization and modelling
Fouad, Irari,Mechbal, Zouhair,Chane-Ching, Kathleen I.,Adenier, Alain,Maurel, Francois,Aaron, Jean-Jacques,Vodicka, Petr,Cernovska, Katerina,Kozmik, Vaclav,Svoboda, Jiri
, p. 1711 - 1721 (2004)
New conducting polymers, including poly[thieno[3,2-b][1]benzothiophene] (poly-TBT) and poly [6-methoxythieno[3,2-b][1]benzothiophene] (poly-MeOTBT) were electrosynthesized by anodic oxidation of the corresponding monomers in 0.1 M LiClO4 acetonitrile solution. Poly-TBT and poly-MeOTBT electroactive films were formed on platinum electrodes and characterized spectroscopically. FT-IR studies show that both polymers present couplings occurring on the thiophene moiety and the phenyl ring, with a step-like structure. MALDI-TOF mass spectrometry indicates that poly-TBT and poly-MeOTBT films are mainly constituted of short-chain oligomers. The results of molecular orbital (MO) calculations performed on the basis of a radical-cation electropolymerization mechanism are in good agreement with our spectral data.
Efficient preparation method of 3-substitued-benzo five-membered heterocycle-2-carbonyl compound
-
Paragraph 0207-0209, (2017/08/30)
The invention discloses an efficient compounding method of a 3-substitued-benzo five-membered heterocycle-2-carbonyl compound. According to the method, a 3-substitued-benzo five-membered heterocycle-2-alcohol compound is subjected to a halogenated oxidation reaction by a halogenating reagent to generate the corresponding 3-substitued-benzo five-membered heterocycle-2-carbonyl compound. The efficient compounding method has the advantages that raw materials are easy to get, reaction conditions are mild, and reaction selectively and yield are high.
Agents and methods for treating ischemic and other diseases
-
, (2016/06/01)
This invention relates to compounds that modulate TRPM7 protein activity and use of the same for treatment or prophylaxis of ischemia, cancer, pain or glaucoma.